|
Inside This Issue - Opinion
The just-concluded 2012 Annual Meeting of the National Association of Chain Drug Stores, by all accounts one of the most productive in the series, has inspired some random observations. A little over a year has passed since Larry Merlo succeeded Tom Ryan as chief executive officer of CVS Caremark. During that time it has become clear that the company is in the hands of a steward who understands its unique combination of assets — a drug chain and a pharmacy benefits management business that are both leaders in their field — and is intent on deploying them for the good of patients, payers and shareholders.
|
